Results 111 to 120 of about 24,116 (174)

Natural variation in OsMYB305 downregulating cytokinin‐mediated inhibition of leaf senescence contributes to regional adaptation in rice

New Phytologist, Volume 251, Issue 4, Page 1873-1888, August 2026.
Proposed regulatory model of OsMYB305 in leaf senescence. Summary Accumulating evidence has identified transcription factors (TFs) as key regulators of the onset and progression of leaf senescence. However, the regulatory role of the rice myeloblastosis (MYB) TF OsMYB305 in this process remains largely unknown.
Boyeong Kim, Jinah Kim, Yejin Shim, Jinku Kang, Hyeryung Yoon, Sung‐Hwan Cho, Nam‐Chon Paek, Kiyoon Kang   +7 more
wiley   +1 more source

Regulatory Mechanism of CsMYB1‐CsMYB82/CsbHLH48‑CsCAD4 Model for Resistance Against Colletotrichum gloeosporioides in Camellia sinensis

Plant Biotechnology Journal, Volume 24, Issue 8, Page 4725-4747, August 2026.
ABSTRACT Anthracnose caused by Colletotrichum gloeosporioides is a major threat to tea cultivation; however, the molecular mechanism underlying different resistance among tea cultivars remains unclear. We identified distinct expression patterns of CsMYB82 between anthracnose‐resistant and susceptible varieties after infection with anthracnose from ...
Rui Han, Yu Wang, Zekun Xue, Wang Wei, Cunqiang Ma, Jiake Zheng, Wuchen Yin, Zhen Zhao, Shujing Liu, Yuhua Wang, Jing Zhuang, Xuan Chen, Shifu Ma, Qiwei Huang, Xinghui Li   +14 more
wiley   +1 more source

Systemic infection of tobacco mosaic virus is limited by upward transport and phloem unloading without coat protein

The Plant Journal, Volume 127, Issue 3, August 2026.
SUMMARY Coat protein (CP) is widely viewed as essential for systemic infection of tobacco mosaic virus (TMV), yet the mechanistic basis of this requirement remains incompletely resolved. In this study, we show that TMV can still achieve long‐distance vascular transport in the absence of CP, but systemic infection becomes intermittent because the ...
Minhue Jung, Kook‐Hyung Kim
wiley   +1 more source

High-throughput identification of bacterial β-glucuronidase inhibitors using machine learning. [PDF]

Gut Microbes
Zhang B, Yue H, Skalse A, Sangfuang N, Shorthouse D, Gaisford S, Basit AW.   +6 more
europepmc   +1 more source

β-Glucuronidase at the Microbiota-Host Interface: Dual Regulatory Roles and Precision Modulation by Natural Products. [PDF]

Molecules
Shen J, Xu S, Zhao Q, Zhang J, Zhang H.
europepmc   +1 more source

SCO6992, a Protein with β-Glucuronidase Activity, Complements a Mutation at the absR Locus and Promotes Antibiotic Biosynthesis in Streptomyces coelicolor. [PDF]

J Microbiol Biotechnol, 2021
Jin XM, Choi MY, Tsevelkhoroloo M, Park U, Suh JW, Hong SK.   +5 more
europepmc   +1 more source

In Silico Structural Analysis of Human β-Glucuronidase for Antibody-Drug Conjugates Optimization. [PDF]

Proteins
Canini G, Saporiti S, Coppa C, Rossi M, Centola F, Arcovito A.   +5 more
europepmc   +1 more source

Characterization of the β-glucuronidase Pn3Pase as the founding member of glycoside hydrolase family GH169. [PDF]

Glycobiology, 2021
Wantuch PL, Jella S, Duke JA, Mousa JJ, Henrissat B, Glushka J, Avci FY.   +6 more
europepmc   +1 more source

The role of gut microbial β-glucuronidase in drug disposition and development. [PDF]

Drug Discov Today, 2022
Gao S, Sun R, Singh R, Yu So S, Chan CTY, Savidge T, Hu M.   +6 more
europepmc   +1 more source